The group includes the American Hospital Association, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists, Institute for Safe Medication Practices and The Pew Charitable Trusts.
Some of the recommendations, according to the Pharmaceutical-Journal, include:
• Manufacturers should be allowed to sell trial batches of drugs that meet quality specifications to mitigate shortages.
• Pharmaceutical companies should be incentivised to invest in capacity and reliability to prevent supply disruptions.
• Regulatory review processes for plant upgrades and repairs needs to be sped up.
• Greater synchronisation is needed between the processes of international regulators.
The report is a result of a summit held in August 2014 comprising of the aforementioned groups.
More articles on ASC news:
Waldorf Endoscopy Center earns AAAHC accreditation
6 recent physician-owned ASC openings, plans
7 things for ASC leaders to know for Thursday
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.